Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinib.
about
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewLow Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIsAssociation between serum C-reactive protein value and prognosis of patients with non-small cell lung cancer: a meta-analysisPrediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.
P2860
Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinib.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Clinical significance of pretr ...... cancer who received gefitinib.
@en
Clinical significance of pretr ...... cancer who received gefitinib.
@nl
type
label
Clinical significance of pretr ...... cancer who received gefitinib.
@en
Clinical significance of pretr ...... cancer who received gefitinib.
@nl
prefLabel
Clinical significance of pretr ...... cancer who received gefitinib.
@en
Clinical significance of pretr ...... cancer who received gefitinib.
@nl
P2093
P2860
P356
P1433
P1476
Clinical significance of pretr ...... cancer who received gefitinib.
@en
P2093
Akiko Fukuhara
Chiyuki Okuda
Hiroki Nagai
Kaoru Irisa
Katsuhiro Masago
Michiaki Mishima
Shiro Fujita
Tadashi Mio
Yosuke Togashi
Young Hak Kim
P2860
P304
P356
10.1159/000323486
P577
2010-01-01T00:00:00Z